Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

Por Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicado em 2012

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma

Por Davidson, Ben, McFadden, Erin, Holth, Arild, Brunetti, Marta, Flørenes, Vivi Ann
Publicado no Virchows Arch (2020)

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma

Por Flørenes, Vivi Ann, Emilsen, Elisabeth, Dong, Hiep Phuc, Førsund, Mette, Holm, Ruth, Slipicevic, Ana
Publicado no Cancer Med (2015)

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes

Por Wang, Zhihui, Trope, Claes G, Flørenes, Vivi Ann, Suo, Zhenhe, Nesland, Jahn M, Holm, Ruth
Publicado em 2010

Collateral Expression of Proangiogenic and Tumorigenic Properties in Intestinal Epithelial Cell Variants Selected for Resistance to Anoikis

Por Rak, Janusz, Mitsuhashi, Yoshihiro, Sheehan, Cap, Krestow, Julia K, Florenes, Vivi Ann, Filmus, Jorge, Kerbel, Robert S
Publicado em 1999

Protein Expression of the Cell-Cycle Inhibitor p27(Kip1) in Malignant Melanoma : Inverse Correlation with Disease-Free Survival

Por Flørenes, Vivi Ann, Mælandsmo, Gunhild M., Kerbel, Robert S., Slingerland, Joyce M., Nesland, Jahn M., Holm, Ruth
Publicado em 1998

E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27(KIP1)

Por St. Croix, Brad, Sheehan, Capucine, Rak, Janusz W., Flørenes, Vivi Ann, Slingerland, Joyce M., Kerbel, Robert S.
Publicado em 1998

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy

Por Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann
Publicado em 2012

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients

Por Magnussen, Gry Irene, Hellesylt, Ellen, Nesland, Jahn M, Trope, Claes G, Flørenes, Vivi Ann, Holm, Ruth
Publicado em 2013

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells

Por Slipicevic, Ana, Jørgensen, Kjersti, Skrede, Martina, Rosnes, Anne Katrine Ree, Trøen, Gunhild, Davidson, Ben, Flørenes, Vivi Ann
Publicado em 2008

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

Por Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Publicado no Cell Death Discov (2016)

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

Por Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Publicado em 2012

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

Por Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Publicado no BMC Cancer (2015)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

Por Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Publicado em 2013

Soluble AXL as a marker of disease progression and survival in melanoma

Por Flem-Karlsen, Karine, Nyakas, Marta, Farstad, Inger Nina, McFadden, Erin, Wernhoff, Patrik, Jacobsen, Kari Dolven, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicado no PLoS One (2020)

Candidate Genes for Testicular Cancer Evaluated by In Situ Protein Expression Analyses on Tissue Microarrays

Por Skotheim, Rolf I, Abeler, Vera M, Nesland, Jahn M, Fosså, Sophie D, Holm, Ruth, Wagner, Urs, Flørenes, Vivi Ann, Aass, Nina, Kallioniemi, Olli P, Lothe, Ragnhild A
Publicado em 2003

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

Por Dillard, Pierre, Köksal, Hakan, Maggadottir, Solrun Melkorka, Winge-Main, Anna, Pollmann, Sylvie, Menard, Mathilde, Myhre, Marit Renée, Mælandsmo, Gunhild M., Flørenes, Vivi Ann, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
Publicado no Mol Ther (2021)

MX2 is a novel regulator of cell cycle in melanoma cells

Por Juraleviciute, Marina, Pozniak, Joanna, Nsengimana, Jérémie, Harland, Mark, Randerson-Moor, Juliette, Vernhoff, Patrik, Bassarova, Assia, Øy, Geir Frode, Trøen, Gunhild, Flørenes, Vivi Ann, Bishop, David Timothy, Herlyn, Meenhard, Newton-Bishop, Julia, Slipicevic, Ana
Publicado no Pigment Cell Melanoma Res (2019)

Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

Por Schaner, Marci E, Davidson, Ben, Skrede, Martina, Reich, Reuven, Flørenes, Vivi Ann, Risberg, Björn, Berner, Aasmund, Goldberg, Iris, Givant-Horwitz, Vered, Tropè, Claes G, Kristensen, Gunnar B, Nesland, Jahn M, Børresen-Dale, Anne-Lise
Publicado em 2005

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases()

Por Flørenes, Vivi Ann, Flem-Karlsen, Karine, McFadden, Erin, Bergheim, Inger Riise, Nygaard, Vigdis, Nygård, Vegard, Farstad, Inger Nina, Øy, Geir Frode, Emilsen, Elisabeth, Giller-Fleten, Karianne, Ree, Anne Hansen, Flatmark, Kjersti, Gullestad, Hans Petter, Hermann, Robert, Ryder, Truls, Wernhoff, Patrik, Mælandsmo, Gunhild Mari
Publicado no Transl Oncol (2019)